Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (128 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 24 Jan 2024 – 20 Aug 2026, limited by Tata Gold ETF Fund of Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Tata Gold ETF Fund of Fund | Gold |
|---|---|---|
| 24 Jan 2024 | ₹100.00 | ₹100.00 |
| 11 Apr 2024 | ₹113.52 | ₹114.57 |
| 29 Jun 2024 | ₹113.11 | ₹114.59 |
| 15 Sep 2024 | ₹114.72 | ₹116.50 |
| 02 Dec 2024 | ₹118.94 | ₹120.51 |
| 18 Feb 2025 | ₹133.43 | ₹136.04 |
| 08 May 2025 | ₹149.66 | ₹152.98 |
| 25 Jul 2025 | ₹151.74 | ₹155.17 |
| 11 Oct 2025 | ₹184.99 | ₹190.27 |
| 28 Dec 2025 | ₹210.09 | ₹216.05 |
| 17 Mar 2026 | ₹234.00 | ₹242.34 |
| 03 Jun 2026 | ₹232.81 | ₹241.24 |
| 20 Aug 2026 | ₹234.64 | ₹243.58 |
| Metric | Tata · Regular · IDCW NAV ₹23.59 High risk ★★★★☆ 1Y | Category median FoF Domestic · 128 funds |
|---|---|---|
| +54.75% | +5.71% | |
| — | +10.60% | |
| — | +7.04% | |
| — | +8.12% | |
| +39.34% | +8.44% | |
| +41.01% | — | |
| — | +9.37% | |
| — | +8.64% | |
| — | +8.30% | |
| Risk | ||
| 22.35% | 13.12% | |
| 2.16 | 0.40 | |
| 3.10 | 0.57 | |
| -24.29% | -18.33% | |
| Gold | — | |
| -2.32% | +0.09% | |
| 1.03 | 0.95 | |
| 96.8% | 92.9% | |
| 100.3% | 81.4% | |
| 0.64% | 0.58% | |
| ₹1,392Cr | ₹372.62Cr | |
| 0.50% | — | |
| None | — | |
| ₹150 | — | |
| ₹5.00K | — | |
| 8% | 13% | |
| Kapil Menon | — | |
| 24 Jan 2024 | — | |
| — | — | |
| — | — | |
| 0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.